- Advertisement -

BioRescue produces primordial germ cells from northern white rhino stem cells – a world’s first for large mammals

In its race to advance assisted reproduction and stem cell associated technologies to save the northern white rhinoceros from extinction, the BioRescue consortium announces...

DNA Barcoding Technology for High Throughput Cell-Nanoparticle Study

Advances in sequencing technologies have accelerated the discovery of the genetic causation of diseases and new cell types. This revolution has also given rise...

Adagio Aims to “Set the Bar Higher”

Six months after launching, then raising $130 million in two financing rounds, Adagio Therapeutics is heading into the clinic with an antibody that has...

The ‘purrfect’ music for calming cats

Credit: Image courtesy of Abi Tansley Taking a cat to the vets can be a stressful experience, both for cat and owner. However, a study...

Highly sensitive Raman probe detects enzyme expression in heterogeneous tissues

Raman imaging offers a greater potential for detecting multiple enzyme activities than fluorescence imaging, demonstrate Tokyo Tech researchers by developing 9CN-rhodol-based activatable Raman probes...

Alzheimer’s Disease and Tau Tangle Proteinopathies Linked to Protein that Prevents...

Studies by researchers at University of South Florida Health (USF Health) Morsani College of Medicine have found that a protein known as β-arrestin2 increases...

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase...

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne...

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase III Trial

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

more new items

Novartis Shares Slide After Neuromuscular Candidate Acquired with Avidity Fails Phase...

Novartis shares fell the most in a single day since the COVID-19 pandemic after the pharma giant acknowledged that its neuromuscular candidate delpacibart etedesiran...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne...

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...